Searches , social queries for CIRCULATING TUMOR-DNA

Search references for CIRCULATING TUMOR-DNA. Phrases containing CIRCULATING TUMOR-DNA

See searches and references containing CIRCULATING TUMOR-DNA!

Searches containing CIRCULATING TUMOR-DNA

CIRCULATING TUMOR-DNA

  • Circulating tumor DNA
  • Tumor-derived fragmented DNA in the bloodstream

    Circulating tumor DNA (ctDNA) is tumor-derived fragmented DNA in the bloodstream that is not associated with cells. ctDNA should not be confused with

    Circulating tumor DNA

    Circulating tumor DNA

    Circulating_tumor_DNA

  • Circulating free DNA
  • Degraded DNA fragments circulating in bodily fluids

    nucleases. The term cfDNA can be used to describe various forms of DNA freely circulating in body fluids, including circulating tumor DNA (ctDNA), cell-free mitochondrial

    Circulating free DNA

    Circulating_free_DNA

  • Liquid biopsy
  • Sampling and analysis of non-solid biological tissues

    biopsy of circulating tumor DNA for EGFR-mutated lung cancer is approved by the FDA. The CellSearch method for enumeration of circulating tumor cells in

    Liquid biopsy

    Liquid_biopsy

  • CAPP-Seq
  • DNA sequencing method

    Digital Error Suppression (iDES). The use of ctDNA in this technique should not be confused with circulating tumor cells (CTCs); these are two different entities

    CAPP-Seq

    CAPP-Seq

  • Helmy Eltoukhy
  • American scientist and entrepreneur

    developed new methods to detect and monitor the low levels of circulating tumor DNA (ctDNA) fragments released into the bloodstream of people who have cancer

    Helmy Eltoukhy

    Helmy Eltoukhy

    Helmy_Eltoukhy

  • Circulating mitochondrial DNA
  • Circulating mitochondrial DNA, also called cell-free circulating mitochondrial DNA and circulating cell-free mitochondrial DNA (ccf mtDNA), are short

    Circulating mitochondrial DNA

    Circulating_mitochondrial_DNA

  • Biopsy
  • Medical test involving extraction of sample cells or tissues for examination

    cell-free circulating tumor DNA (cfDNA) assays over circulating tumor cells assays in that there is approximately 100 times more cell-free DNA than there

    Biopsy

    Biopsy

    Biopsy

  • Tumor-informed minimal residual disease
  • Type of minimal residual disease

    in cancer patients. It primarily analyzes circulating tumor DNA (ctDNA)—small fragments of DNA shed from tumor cells into the blood plasma. This method

    Tumor-informed minimal residual disease

    Tumor-informed_minimal_residual_disease

  • Tumor-agnostic minimal residual disease
  • Type of minimal residual disease

    minimal residual disease (MRD) using circulating tumor DNA (ctDNA) analysis that does not require prior sequencing of a tumor tissue. Instead, these assays analyze

    Tumor-agnostic minimal residual disease

    Tumor-agnostic_minimal_residual_disease

  • Natera
  • American clinical genetic testing company

    increased risk for common hereditary cancers. Signatera is the first circulating tumor DNA (ctDNA) assay built for molecular residual disease (MRD) detection and

    Natera

    Natera

  • EPIC-Seq
  • Cell-free DNA profiling method

    Derek (2017-08-16). "Direct detection of early-stage cancers using circulating tumor DNA". Science Translational Medicine. 9 (403) eaan2415. doi:10.1126/scitranslmed

    EPIC-Seq

    EPIC-Seq

  • Nervous system tumor
  • Medical condition

    Hui (2019). "Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA". Acta Neuropathologica. 137 (2): 297–306

    Nervous system tumor

    Nervous system tumor

    Nervous_system_tumor

  • Metastasis
  • Spreading of a disease inside a body

    cancer cells, known as circulating tumor cells (CTCs), are able to penetrate the walls of lymphatic or blood vessels, and circulate through the bloodstream

    Metastasis

    Metastasis

    Metastasis

  • Ash Alizadeh
  • Iranian-American physician-scientist

    Laboratory at Stanford. His group studies tumor heterogeneity, immune–tumor interactions, and circulating tumor DNA (ctDNA) dynamics in lymphoma and solid cancers

    Ash Alizadeh

    Ash Alizadeh

    Ash_Alizadeh

  • Guardant Health
  • American biotechnology company

    discovered a technique which "involves detecting and monitoring tumor fragments circulating in the patient's bloodstream", as an alternative to traditional

    Guardant Health

    Guardant_Health

  • Urinary cell-free DNA
  • release high- or low-molecular-weight DNA fragments via apoptosis and necrosis, while circulating cell-free DNA (cfDNA) that passes through glomerular pores

    Urinary cell-free DNA

    Urinary_cell-free_DNA

  • Cancer Likelihood in Plasma
  • personalized profiling by deep sequencing (CAPP-Seq) for analysis of circulating tumor DNA (ctDNA). The CLiP technique integrates multiple distinctive genomic

    Cancer Likelihood in Plasma

    Cancer_Likelihood_in_Plasma

  • Liver cancer
  • Medical condition

    addressing GPC3-positive tumors, especially in pediatric liver cancers. New researches focus on blood-based biomarkers, circulating tumor DNA, artificial intelligence-assisted

    Liver cancer

    Liver cancer

    Liver_cancer

  • Adrenal tumor
  • Tumors of the adrenal gland

    hypermethylation of DNA. Carcinomas were determined to be caused by mutations in Wnt and p53 pathways. Both adenoma and carcinoma tumors of the adrenal cortex

    Adrenal tumor

    Adrenal_tumor

  • Duplex sequencing
  • Preparation and analysis method for DNA

    mosaicism, subclonal variants in genetically heterogeneous cancers, or circulating tumor DNA. Several library preparation strategies have been developed that

    Duplex sequencing

    Duplex sequencing

    Duplex_sequencing

  • Central nervous system prophylaxis
  • Recently, molecular analysis on tumour DNA has gained growing popularity. Detection of ctDNA (circulating tumor DNA) within CSF offers promising directions

    Central nervous system prophylaxis

    Central_nervous_system_prophylaxis

  • Tumor necrosis factor
  • Immune system messenger protein which induces inflammation

    Tumor necrosis factor (TNF), formerly known as TNF-α, is a chemical messenger produced by the immune system that induces inflammation. TNF is produced

    Tumor necrosis factor

    Tumor necrosis factor

    Tumor_necrosis_factor

  • Carrier DNA
  • Inert DNA used to improve the efficiency of nucleic acid precipitation and purification

    Vladimír (1 January 2016). "Carrier molecules and extraction of circulating tumor DNA for next generation sequencing in colorectal cancer". Acta Medica

    Carrier DNA

    Carrier_DNA

  • Cancer
  • Group of diseases involving cell growth

    resulting in tumors with the potential to invade or spread to other parts of the body. These malignant tumors contrast with benign tumors, which do not

    Cancer

    Cancer

    Cancer

  • Noninvasive genotyping
  • incidence of tumor DNA in the blood, which can both provide early detection of tumor growth and indicate relapse in cancer. Circulating tumor DNA can be found

    Noninvasive genotyping

    Noninvasive_genotyping

  • Tumour heterogeneity
  • Observation of the diversity of tumour cells

    Wallis, M; Bentley, D; Caldas, C; Rosenfeld, N (2013). "Analysis of circulating tumor DNA to monitor metastatic breast cancer". New England Journal of Medicine

    Tumour heterogeneity

    Tumour_heterogeneity

  • Minimal residual disease
  • Persistence of some cancer cells during remission

    (start, stop or change) DNA tests are based on detecting circulating tumor DNA in the blood that contains cancer-specific DNA sequences. Modern techniques

    Minimal residual disease

    Minimal residual disease

    Minimal_residual_disease

  • Fragmentomics
  • sources, such as circulating tumour DNA (ctDNA) and cell-free fetal DNA (cffDNA). Furthermore, the cell of origin and mechanism of cfDNA release lead to

    Fragmentomics

    Fragmentomics

    Fragmentomics

  • Maximilian Diehn
  • American radiation oncologist and cancer biologist

    the use of circulating tumor DNA (ctDNA) as a non-invasive biomarker. His laboratory has developed techniques for detecting and analyzing ctDNA, which can

    Maximilian Diehn

    Maximilian_Diehn

  • Sophia Genetics
  • Health technology company

    Platform (Data-Driven Medicine), which helps to interpret circulating tumor DNA and circulating tumour cells in blood, urine, cerebral spinal fluid and

    Sophia Genetics

    Sophia_Genetics

  • DNA methylation
  • Biological process

    DNA methylation is a biological process by which methyl groups are added to the DNA molecule. Methylation can change the activity of a DNA segment without

    DNA methylation

    DNA methylation

    DNA_methylation

  • Richard B. Lanman
  • American biotechnology entrepreneur, physician scientist and naturalist

    Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA Sequencing". J Clin Oncol. 36 (35): JCO1800328. doi:10

    Richard B. Lanman

    Richard B. Lanman

    Richard_B._Lanman

  • Brain tumor
  • Neoplasm in the brain

    main types of tumors: malignant (cancerous) tumors and benign (non-cancerous) tumors. These can be further classified as primary tumors, which start within

    Brain tumor

    Brain tumor

    Brain_tumor

  • Biomarker (medicine)
  • Measurable indicator

    2014, Cancer research identified Circulating Tumor Cells (CTCs) and Circulating Tumor DNA (ctDNA) as metastasizing tumor biomarkers with special cellular

    Biomarker (medicine)

    Biomarker_(medicine)

  • Lung cancer
  • Malignant tumor characterized by uncontrolled cell growth in lung tissue

    Lung cancer is a malignant tumor that originates in the tissues of the lungs. Lung cancer is caused by genetic damage to the DNA of cells in the airways

    Lung cancer

    Lung cancer

    Lung_cancer

  • Cancer biomarker
  • Substance or process that is indicative of the presence of cancer in the body

    tumor can be identified as a distinct primary tumor. For example, people with tumors have high levels of circulating tumor DNA (ctDNA) due to tumor cells

    Cancer biomarker

    Cancer biomarker

    Cancer_biomarker

  • Bert Vogelstein
  • American oncologist (born 1949)

    Kinzler KW; Vogelstein B; Diaz LA Jr. (September 2018). "Circulating mutant DNA to assess tumor dynamics". Nat. Med. 14 (9): 985–90. doi:10.1038/nm.1789

    Bert Vogelstein

    Bert Vogelstein

    Bert_Vogelstein

  • Digital polymerase chain reaction
  • Biotechnological procedure

    monitor tumor load, treatment response and disease progression in cancer patients by measuring rare mutations in circulating tumor DNA (ctDNA) in a variety

    Digital polymerase chain reaction

    Digital_polymerase_chain_reaction

  • Genetic heterogeneity
  • Different genetic causes for the same disease

    profiling, using techniques like liquid biopsy (e.g., circulating tumor DNA or ctDNA), can capture tumor-derived genetic material shed into blood or other

    Genetic heterogeneity

    Genetic heterogeneity

    Genetic_heterogeneity

  • Dennis Lo
  • Hong Kong molecular biologist

    the presence of cell-free fetal DNA in most of the test subjects. This was after he read that circulating tumor DNA were detectable in cancer patients'

    Dennis Lo

    Dennis Lo

    Dennis_Lo

  • Microvesicle
  • Type of extracellular vesicle

    instrument for developing tumor vaccines. Circulating miRNA and segments of DNA in all body fluids can be potential markers for tumor diagnostics. Rheumatoid

    Microvesicle

    Microvesicle

    Microvesicle

  • Talazoparib
  • Chemical compound

    PALB2, or RAD51C) were assessed prospectively using tumor tissue and/or circulating tumor DNA (ctDNA)-based next generation sequencing assays. Talazoparib

    Talazoparib

    Talazoparib

    Talazoparib

  • BEAMing
  • tumor DNA molecules among a large background of wild-type DNA. BEAMing is often used in cancer research to conduct assessments of circulating tumor DNA

    BEAMing

    BEAMing

  • Tumor microenvironment
  • Surroundings of tumors including nearby cells and blood vessels

    The tumor microenvironment is a complex ecosystem surrounding a tumor, composed of cancer cells, stromal tissue (including blood vessels, immune cells

    Tumor microenvironment

    Tumor microenvironment

    Tumor_microenvironment

  • Victor Velculescu
  • Cancer genomics researcher

    VE (June 2014). "Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA". Cancer Discovery. 4 (6): 650–61. doi:10.1158/2159-8290

    Victor Velculescu

    Victor Velculescu

    Victor_Velculescu

  • Whole genome sequencing
  • Sequencing all the DNA of an individual at once

    as it makes it possible to analyze, quantify and characterize circulating tumor DNA (ctDNA) in the bloodstream. This serves as a basis for early cancer

    Whole genome sequencing

    Whole genome sequencing

    Whole_genome_sequencing

  • John V. Heymach
  • Papadimitrakopoulou VA, Heymach JV. Genotype-specific differences in circulating tumor DNA levels in advanced NSCLC. J Thorac Oncol 16(4):601-609, 2021. e-Pub

    John V. Heymach

    John_V._Heymach

  • Nitzan Rosenfeld
  • Cancer researcher

    Jennifer; Halsall, David; Wallis, Matthew (2013-03-28). "Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer". New England Journal of Medicine

    Nitzan Rosenfeld

    Nitzan_Rosenfeld

  • Prognosis marker
  • Medical term

    alternative DNA source is circulating tumor DNA (ctDNA). ctDNA primarily originates from apoptotic and necrotic tumor cells that release their fragmented DNA into

    Prognosis marker

    Prognosis_marker

  • Alain R. Thierry
  • French geneticist and cancer researcher

    specializes in the clinical applications of liquid biopsy that exploits circulating DNA as a biomarker, notably in cancer care management. He is currently

    Alain R. Thierry

    Alain R. Thierry

    Alain_R._Thierry

  • Sarah-Jane Dawson
  • Australian clinician-scientist

    study of cell-free circulating tumour DNA in patients with cancer. Many cancers shed small amounts of DNA (called circulating tumour DNA) into the patient's

    Sarah-Jane Dawson

    Sarah-Jane_Dawson

  • The Hallmarks of Cancer
  • 2000 paper by Hanahan and Weinberg

    tumor suppressor genes. These genes take information from the cell to ensure that it is ready to divide, and will halt division if not (when the DNA is

    The Hallmarks of Cancer

    The Hallmarks of Cancer

    The_Hallmarks_of_Cancer

  • MicroDNA
  • Subtype of DNA

    longer circulating microDNA sequences in cancer patients pre-tumor removal. The length of cfmicroDNA was found to be shorter post-surgery. Cell-free DNA is

    MicroDNA

    MicroDNA

    MicroDNA

  • Trevor Pugh
  • Canadian researcher

    effectiveness non-invasively. His work has demonstrated that changes in circulating tumor DNA (ctDNA) levels can predict patient responses to immunotherapy. He also

    Trevor Pugh

    Trevor_Pugh

  • Martin Gleave
  • Canadian surgeon and cancer researcher

    Reviews Cancer'' 5(6):468–479 (2005). Wyatt AW et al. "Concordance of circulating tumor DNA and matched metastatic tissue biopsy in prostate cancer." ''Journal

    Martin Gleave

    Martin_Gleave

  • Cancer screening
  • Method to detect cancer

    hereditary cancer tests since they detect the presence of cancer through circulating tumor DNA in the blood. More MCED tests are currently in development. The

    Cancer screening

    Cancer screening

    Cancer_screening

  • Henry Brem
  • American medical researcher

    i10-index of 355. His 10 most cited works include: Detection of circulating tumor DNA in early-and late-stage human malignancies, doi: 10.1126/scitranslmed

    Henry Brem

    Henry_Brem

  • Methylated DNA immunoprecipitation
  • Purification technique

    analyzing the methylation patterns of cfDNA, it is possible to identify tumor-specific epigenetic signatures circulating in the bloodstream, offering a non-invasive

    Methylated DNA immunoprecipitation

    Methylated_DNA_immunoprecipitation

  • RET inhibitor
  • they are limited by how much circulating tumor DNA is present in the sample, which itself depends upon how much DNA the tumors shed into the blood. This

    RET inhibitor

    RET inhibitor

    RET_inhibitor

  • Maurice Stroun
  • disease-specific circulating nucleic acids as well as first developing techniques for the detection of tumor-related characteristics of circulating DNA and RNA

    Maurice Stroun

    Maurice Stroun

    Maurice_Stroun

  • Glossary of cellular and molecular biology (0–L)
  • plastid DNA, as well as many other varieties of extrachromosomal DNA, including plasmids and some viral DNA. Contrast linear DNA. circulating tumor DNA (ctDNA)

    Glossary of cellular and molecular biology (0–L)

    Glossary_of_cellular_and_molecular_biology_(0–L)

  • Ruth March
  • British genomic scientist

    to create tests based on circulating tumor DNA (ctDNA). These tests can isolate specific signals from the background of DNA noise. They can be used to

    Ruth March

    Ruth March

    Ruth_March

  • Immune system
  • Biological system protecting an organism against disease

    against tumor antigens, so the immune system no longer attacks the tumor cells. Paradoxically, macrophages can promote tumor growth when tumor cells send

    Immune system

    Immune system

    Immune_system

  • Alberto Bardelli
  • Italian geneticist

    S2CID 1478003. Siravegna, Giulia; Bardelli, Alberto (March 2016). "Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients". Molecular

    Alberto Bardelli

    Alberto Bardelli

    Alberto_Bardelli

  • William K. Oh
  • American cancer researcher

    1016/S1470-2045(12)70263-2. PMID 23059047. Jun T, Oh WK (July 2022). ""Does Circulating Tumor DNA Measure Up to Prostate-Specific Antigen?"". JAMA Oncol. 8 (7): 972–974

    William K. Oh

    William_K._Oh

  • Shan X. Wang
  • Materials scientist

    matrix-insensitive measurements. Clinical applications include a circulating-tumor-DNA assay for EGFR mutations with an analytical sensitivity of 0.01%

    Shan X. Wang

    Shan X. Wang

    Shan_X._Wang

  • Luis A. Diaz
  • American oncologist

    Katherine; Agrawal, Nishant; Sokoll, Lori (September 2008). "Circulating mutant DNA to assess tumor dynamics". Nature Medicine. 14 (9): 985–990. doi:10.1038/nm

    Luis A. Diaz

    Luis_A._Diaz

  • Healthier Lives
  • Collaborative public health research programme in New Zealand (2015–2024)

    Cristin; Jackson, Christopher; Guilford, Parry (13 November 2020). "Circulating tumor DNA is a sensitive marker for routine monitoring of treatment response

    Healthier Lives

    Healthier Lives

    Healthier_Lives

  • MSH2
  • Protein found in humans

    located on chromosome 2. MSH2 is a tumor suppressor gene and more specifically a caretaker gene that codes for a DNA mismatch repair (MMR) protein, MSH2

    MSH2

    MSH2

    MSH2

  • Endothelial progenitor cell
  • Cell type

    "Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth". Proc. Natl. Acad

    Endothelial progenitor cell

    Endothelial_progenitor_cell

  • Hepatocellular carcinoma
  • Common type of liver cancer

    higher circulating insulin concentration) show far greater risk of hepatocellular carcinoma than diabetics on treatments that reduce circulating insulin

    Hepatocellular carcinoma

    Hepatocellular carcinoma

    Hepatocellular_carcinoma

  • Mouse models of breast cancer metastasis
  • Cancer research

    metastasis is to look for circulating tumor cells in transgenic mice e.g. MMTV-PyMT mice can respond to various therapies in shedding tumor cells in the blood

    Mouse models of breast cancer metastasis

    Mouse_models_of_breast_cancer_metastasis

  • Polymerase chain reaction
  • Laboratory technique to multiply a DNA sample for study

    DNA samples for prenatal testing can be obtained by amniocentesis, chorionic villus sampling, or even by the analysis of rare fetal cells circulating

    Polymerase chain reaction

    Polymerase chain reaction

    Polymerase_chain_reaction

  • Focused ultrasound-mediated diagnostics
  • Diagnostic technique

    monitoring of circulating tumor cell release during tumor manipulation using in vivo photoacoustic and fluorescent flow cytometry: Circulating Tumor Cell Release

    Focused ultrasound-mediated diagnostics

    Focused_ultrasound-mediated_diagnostics

  • Fluorescence in situ hybridization
  • Genetic testing technique

    localize specific RNA targets (mRNA, lncRNA, and miRNA) in cells, circulating tumor cells, and tissue samples. In this context, it helps define the spatial

    Fluorescence in situ hybridization

    Fluorescence in situ hybridization

    Fluorescence_in_situ_hybridization

  • In situ hybridization
  • Laboratory technique to localize nucleic acids

    embryos), in the entire tissue (whole mount ISH), in cells, and in circulating tumor cells (CTCs). This is distinct from immunohistochemistry, which usually

    In situ hybridization

    In situ hybridization

    In_situ_hybridization

  • Targeted drug delivery
  • Method of delivering medication

    the drug, reduction of drug side-effects, and reduced fluctuation in circulating drug levels. The disadvantage of the system is high cost, which makes

    Targeted drug delivery

    Targeted_drug_delivery

  • 5-Hydroxymethylcytosine
  • Chemical compound

    patterns in circulating cell-free DNA (cfDNA) for non-invasive cancer detection and stratification. Genome-wide 5hmC profiling of cfDNA identified cancer-type-specific

    5-Hydroxymethylcytosine

    5-Hydroxymethylcytosine

    5-Hydroxymethylcytosine

  • Abscopal effect
  • Hypothesis in the treatment of metastatic cancer

    treatment fields commonly encompass the tumor-draining lymph nodes and a substantial fraction of circulating lymphocytes, both of which are required for

    Abscopal effect

    Abscopal effect

    Abscopal_effect

  • Tumour surveillance theory
  • Immune system theory

    (2021-10-13). "Non-immune Cell Components in the Gastrointestinal Tumor Microenvironment Influencing Tumor Immunotherapy". Frontiers in Cell and Developmental Biology

    Tumour surveillance theory

    Tumour surveillance theory

    Tumour_surveillance_theory

  • Neutrophil extracellular traps
  • Networks of fibres which bind pathogens

    NET-associated biomarkers, including circulating cell-free DNA, histones, myeloperoxidase-DNA complexes, and neutrophil elastase–DNA complexes, have been correlated

    Neutrophil extracellular traps

    Neutrophil extracellular traps

    Neutrophil_extracellular_traps

  • T cell receptor T cell therapy
  • Type of cancer immunotherapy

    2022). "Isolation of TCR genes with tumor-killing activity from tumor-infiltrating and circulating lymphocytes in a tumor rejection cynomolgus macaque model"

    T cell receptor T cell therapy

    T_cell_receptor_T_cell_therapy

  • James R. Eshleman
  • American physician-scientist

    Lisa M.; Yu, Jun; Burkhart, Richard A. (2023-03-31). "Data from Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer". doi.org. doi:10

    James R. Eshleman

    James_R._Eshleman

  • Leptomeningeal cancer
  • Medical condition

    rare complication of cancer in which the disease spreads from the original tumor site to the meninges surrounding the brain and spinal cord. This leads to

    Leptomeningeal cancer

    Leptomeningeal cancer

    Leptomeningeal_cancer

  • G&T-seq
  • PMID 21399628. Xi-Xi Chen, Fan Bai (2015). "Single-cell analyses of circulating tumor cells". 癌症生物学与医学:英文版. 12 (3): 184–192. doi:10.7497/j.issn.2095-3941

    G&T-seq

    G&T-seq

  • Breast cancer classification
  • Medical classification system

    distant metastases M0(i+): Molecularly or microscopically detected tumor cells in circulating blood, bone marrow or non-regional nodal tissue, no larger than

    Breast cancer classification

    Breast cancer classification

    Breast_cancer_classification

  • Single-cell sequencing
  • Examines sequence information from individual cells

    Vetter M, Landin J, Scherrer R, et al. (January 2019). "Circulating Tumor Cell Clustering Shapes DNA Methylation to Enable Metastasis Seeding". Cell. 176

    Single-cell sequencing

    Single-cell_sequencing

  • Salvatore Siena
  • Italian medical oncologist

    Sapino, A.; Marsoni, S.; Siena, S.; Bardelli, A. (August 1, 2022). "Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer:

    Salvatore Siena

    Salvatore Siena

    Salvatore_Siena

  • Cutaneous B-cell lymphoma
  • Medical condition

    (March 2022). "Limitations of Monitoring Disease Progression Using Circulating Tumor DNA in Lymphoma: An Example From Primary Cutaneous DLBCL Leg-type".

    Cutaneous B-cell lymphoma

    Cutaneous B-cell lymphoma

    Cutaneous_B-cell_lymphoma

  • Cancer immunotherapy
  • Artificial stimulation of the immune system to treat cancer

    testing, indicate a deficiency in DNA repair mechanisms and are associated with high mutation rates that may increase tumor immunogenicity. These biomarkers

    Cancer immunotherapy

    Cancer immunotherapy

    Cancer_immunotherapy

  • MicroRNA
  • Small non-coding ribonucleic acid molecule

    explanation for the persistence of non-coding DNA. miRNAs are also found as extracellular circulating miRNAs. Circulating miRNAs are released into body fluids

    MicroRNA

    MicroRNA

    MicroRNA

  • Chromosome abnormality
  • Abnormal number or structure of chromosomes

    chromosomal anomaly is a missing, extra, or irregular portion of chromosomal DNA. These can occur in the form of numerical abnormalities, where there is an

    Chromosome abnormality

    Chromosome_abnormality

  • Medullary thyroid cancer
  • Malignant thyroid neoplasm originating from C-cells

    parafollicular cells (C cells), which produce the hormone calcitonin. Medullary tumors are the third most common of all thyroid cancers and together make up about

    Medullary thyroid cancer

    Medullary thyroid cancer

    Medullary_thyroid_cancer

  • BCL3
  • Protein-coding gene in humans

    mediated response to inflammatory cytokines, and protect colorectal tumor cells against DNA damage. The role of Bcl3 in enabling multiple cancer hallmarks

    BCL3

    BCL3

    BCL3

  • Shelterin
  • Protein complex serving as a telomere cap

    many eukaryotes from DNA repair mechanisms, as well as to regulate telomerase activity. In mammals and other vertebrates, telomeric DNA consists of repeating

    Shelterin

    Shelterin

  • Epigenetics of physical exercise
  • Field of study

    effect of physical exercise on DNA methylation patterns leads to increased expression of genes associated with tumor suppression and decreased expression

    Epigenetics of physical exercise

    Epigenetics_of_physical_exercise

  • Hank Skinner
  • American convicted murderer (1962–2023)

    post-conviction DNA testing upon which the judges relied were too narrow or restrictive. The ruling did not specifically grant Skinner the DNA testing he had

    Hank Skinner

    Hank_Skinner

  • Adrenomedullin
  • Mammalian protein found in humans

    the human body. Initially discovered in 1993 from a pheochromocytoma, a tumor of the adrenal medulla, this 52-amino acid peptide is now recognized for

    Adrenomedullin

    Adrenomedullin

    Adrenomedullin

  • Neutrophil
  • Type of white blood cell

    report may divide neutrophils into segmented neutrophils and bands. When circulating in the bloodstream and inactivated, neutrophils are spherical. Once activated

    Neutrophil

    Neutrophil

    Neutrophil

  • Translationally controlled tumor protein
  • Protein-coding gene in the species Homo sapiens

    Translationally controlled tumor protein was first discovered in 1989 as a cDNA sequence obtained from a human mammary carcinoma cDNA library with proves derived

    Translationally controlled tumor protein

    Translationally controlled tumor protein

    Translationally_controlled_tumor_protein

Searches for online references containing CIRCULATING TUMOR-DNA

CIRCULATING TUMOR-DNA

Search references containing CIRCULATING TUMOR-DNA

CIRCULATING TUMOR-DNA

Search queries for Facebook and twitter posts, hashtags with CIRCULATING TUMOR-DNA

CIRCULATING TUMOR-DNA

Follow users with usernames @CIRCULATING TUMOR-DNA or posting hashtags containing #CIRCULATING TUMOR-DNA

CIRCULATING TUMOR-DNA

Online names & meanings

Search queries for Facebook and twitter users, user names, hashtags with CIRCULATING TUMOR-DNA

CIRCULATING TUMOR-DNA

Top search, Social media, medium, facebook & news articles containing CIRCULATING TUMOR-DNA

CIRCULATING TUMOR-DNA

Searches for Acronyms & meanings containing CIRCULATING TUMOR-DNA

CIRCULATING TUMOR-DNA

Searches, Indeed job searches and job offers containing CIRCULATING TUMOR-DNA

Other words and meanings similar to

CIRCULATING TUMOR-DNA

Search in online dictionary sources & meanings containing CIRCULATING TUMOR-DNA

CIRCULATING TUMOR-DNA

  • Tutor
  • v. t.

    To play the tutor toward; to treat with authority or severity.

  • Windiness
  • n.

    Tumor; puffiness.

  • Tudor
  • a.

    Of or pertaining to a royal line of England, descended from Owen Tudor of Wales, who married the widowed queen of Henry V. The first reigning Tudor was Henry VII.; the last, Elizabeth.

  • Rumor
  • v. t.

    To report by rumor; to tell.

  • Circulatory
  • a.

    Circulating, or going round.

  • Hematocele
  • n.

    A tumor filled with blood.

  • Calculating
  • a.

    Given to contrivance or forethought; forecasting; scheming; as, a cool calculating disposition.

  • Report
  • v. t.

    A story or statement circulating by common talk; a rumor; hence, fame; repute; reputation.

  • Keloid
  • n.

    A keloid tumor.

  • Osteoma
  • n.

    A tumor composed mainly of bone; a tumor of a bone.

  • Tumor
  • n.

    A morbid swelling, prominence, or growth, on any part of the body; especially, a growth produced by deposition of new tissue; a neoplasm.

  • Humor
  • n.

    State of mind, whether habitual or temporary (as formerly supposed to depend on the character or combination of the fluids of the body); disposition; temper; mood; as, good humor; ill humor.

  • Repeater
  • n.

    See Circulating decimal, under Decimal.

  • Circulation
  • n.

    The extent to which anything circulates or is circulated; the measure of diffusion; as, the circulation of a newspaper.

  • Tumor
  • n.

    Affected pomp; bombast; swelling words or expressions; false magnificence or sublimity.

  • Humor
  • v. t.

    To comply with the humor of; to adjust matters so as suit the peculiarities, caprices, or exigencies of; to adapt one's self to; to indulge by skillful adaptation; as, to humor the mind.

  • Afloat
  • adv. & a.

    Moving; passing from place to place; in general circulation; as, a rumor is afloat.

  • Circulation
  • n.

    Currency; circulating coin; notes, bills, etc., current for coin.

  • Circulative
  • a.

    Promoting circulation; circulating.

  • Circulating
  • P. pr. & vb. n.

    of Circulate